Abstract
A method of detecting whether or not a subject has a cancer irrespective of the stage or type of cancer comprises performing an IR spectroscopic analysis comprising wavelengths between 400 4000 cm-1 on a blood sample from the subject, to produce a spectroscopic signature characteristic of the blood sample, wherein said spectroscopic signature of the blood sample is analysed against representative signatures from previous subjects with and without cancer, wherein the subjects with cancer comprise subjects with different types of cancer and different stages of cancer, in order to detect whether or not the subject has a cancer, based upon the spectroscopic signature obtained from the subject.
| Original language | English |
|---|---|
| Patent number | WO2023170410A1 |
| IPC | G01N 21/3577 (2014.01),G01N 21/35 (2014.01),G01N 21/552 (2014.01),G01N 33/487 (2006.01) |
| Priority date | 9/03/22 |
| Filing date | 8/03/23 |
| Publication status | Published - 14 Sept 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Multi-Cancer Detection'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver